Senior insider sale
President and CEO at ORIC PHARMACEUTICALS, INC. — senior position signals high conviction
$3.17M
283.37K shares
What this filing means
CHACKO JACOB plans to sell 283.37K shares of ORIC PHARMACEUTICALS, INC. valued at approximately $3.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/16/2025ACC: 0001608936-25-000013
DirectorOfficer· President and CEO
Since Apr 2020
283.37K
Shares to sell
$3.17M
Approx. market value
83.67K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
12/15/2025
83.67KTotal acquired83.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2025 | Restricted Stock Units N/A | 83.67K | — |
| Total | 83.67K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
37.46K
Market value
$461.5K
10/6/2025
—Completed
Units to sell
53K
Market value
$638.8K
10/1/2025
—Completed
Units to sell
34.54K
Market value
$414.7K
9/30/2025
—Completed
Units to sell
125K
Market value
$1.35M
9/22/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
33.37K
Market value
$302.4K
12/16/2025
Total
Units
283.37K
Value
$3.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/6/2025 | 37.46K | $461.5K | — | Completed |
10/1/2025 | 53K | $638.8K | — | Completed |
9/30/2025 | 34.54K | $414.7K | — | Completed |
9/22/2025 | 125K | $1.35M | — | Completed |
| Planned — Approximate Date | ||||
12/16/2025 | 33.37K | $302.4K | NASDAQ | Planned |
| Total | 283.37K | $3.17M | ||